FdaApplication
NDA 216490
Identifiers
- fda_app_no: NDA216490
Properties
| Property | Value |
|---|---|
| applicant_name | ASCENDIS PHARMA BONE DISEASES AS |
| application_type | NDA |
| approval_date | 2024-08-09 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| YORVIPATH | PALOPEGTERIPARATIDE | EQ 0.168MG TERIPARATIDE/0.56ML (EQ 0.168MG TERIPARATIDE/0.56ML) | SOLUTION;SUBCUTANEOUS |
| YORVIPATH | PALOPEGTERIPARATIDE | EQ 0.294MG TERIPARATIDE/0.98ML (EQ 0.294MG TERIPARATIDE/0.98ML) | SOLUTION;SUBCUTANEOUS |
| YORVIPATH | PALOPEGTERIPARATIDE | EQ 0.42MG TERIPARATIDE/1.4ML (EQ 0.3MG TERIPARATIDE/ML) | SOLUTION;SUBCUTANEOUS |
3 products